Description: The CRRP focuses on forward-deployable solutions that can promptly address life-
threatening injuries, medical threats, and treatments for Warfighters in current and future
battlefield settings, to deliver high-impact medical solutions in diverse operational settings and
closer to the point of injury to increase survivability and Warfighter readiness. The program seeks
to develop innovative solutions to increase medical readiness, mitigate fatalities, optimally treat
life-threatening injuries, and promote positive long-term outcomes. Innovations developed by
CRRP-supported research may be applied proactively as a way to establish medical readiness ahead of
deployment, in operational settings at the point of injury, during periods of prolonged care, or
during transport/ en route between roles of care.
Focus Areas broadly describe current priorities to improve readiness for delivering frontline care
in combat situations and for delivering medical damage control capability, assets, and life- saving
interventions during prolonged and en route care in austere and combat environments, including the
acute and early management of combat-related trauma at the point of injury.
Proposed research must address at least one of the FY22 CRRP Focus Areas; these include
complementary health measures to accelerate return to duty, and regenerative medicine. Focus areas
include solutions to enhance combat care delivery throughout the far-forward environment, such as:
• Telemedicine solutions that enable medical capabilities at far-forward battlespace locations
worldwide
• Medical simulation technology that supports sustainment of critical skills and medical
decision-making
• Solutions for the assessment of mild traumatic brain injury, to include portable and handheld
devices
Proposed research must have the potential for rapid development and translation of applicable
advances for improving medical readiness, mitigating fatalities, optimally treating life-
threatening injuries, and promoting positive long-term outcomes for military health and medicine,
as well as the general public. Supports preclinical research, clinical research, and small-scale
clinical trials (e.g., first in human, phase 1/1b).
Pre-Application (Preproposal) due: June 23, 2022
Proposal/Application due: September 14, 2022
Max Period of Performance: 2 years (3 years with option)
Max Funding: $2.2M total costs (2 years), $1M option year
For more information, full announcements (extramural, intramural), and submission